The emerging treatment of this peptide represents a major development in the management of diabetes mellitus type 2. Unlike existing therapies, tirzepatide targets two pathways – the GLP-1 hormone and GIP – https://tirzepatide-peptide483087.blogspothub.com/40718374/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment